JUVÉDERM VOLBELLA® XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year. This includes optional touch up at one month for optimal correction.
JUVÉDERM VOLBELLA® XC is formulated with VYCROSS®,2 a proprietary filler technology from Allergan, which yields smooth products that have been engineered to address specific patient concerns.
VYCROSS® blends different molecular weights of hyaluronic acid which contributes to the gel’s duration. In addition, JUVÉDERM VOLBELLA® XC has been customized with a lower HA concentration (15 mg/mL), while still providing the long-lasting results healthcare providers expect from the JUVÉDERM® collection of fillers. This makes JUVÉDERM VOLBELLA® XC a soft, smooth gel appropriate for adding subtle volume to the lips and softening the appearance of perioral lines.
Allergan first debuted this innovative VYCROSS® technology in the U.S. in 2013 with the FDA approval of JUVÉDERM VOLUMA® XC for age-related mid-face volume loss. Now JUVÉDERM VOLBELLA® XC is the latest addition to the JUVÉDERM® collection of fillers, the number one selling collection of dermal filler products in the world, to receive FDA approval.
I am excited about JUVÉDERM VOLBELLA® XC for correction of perioral rhytids, more commonly called perioral lines. In the past this area has been difficult to treat. Now, I have a product from the JUVEDERM® Collection of Fillers that is approved to address this specific patient concern.
When it comes to treating the lips, most patients want a smooth-looking result. With JUVÉDERM VOLBELLA® XC, there is now a solution available for patients bothered specifically by lines around the lips, known as perioral lines.
JUVÉDERM VOLBELLA® XC adds fullness to the lips and softens the appearance of the lines around the lips.
The safety and effectiveness of JUVÉDERM VOLBELLA® XC has been demonstrated in several clinical trials including the U.S. pivotal study where 168 subjects were treated with JUVÉDERM VOLBELLA® XC. A 5-point scale was used to evaluate the effectiveness of the product for lip fullness and a 4-point scale to evaluate the effectiveness of the product for smoothing lines around the mouth. Approximately two-thirds of subjects treated with JUVÉDERM VOLBELLA® XC showed improvement in lip fullness and perioral lines through 1 year. The safety of JUVÉDERM VOLBELLA® XC was observed to be similar to that of the control. The most common side effects were temporary responses at the treatment site such as swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, discoloration, and itching. Most of these side effects resolved within 30 days.
JUVÉDERM VOLBELLA® XC will be available to patients in October 2016. For more information about JUVÉDERM VOLBELLA® XC and the JUVÉDERM® collection of fillers or to find a doctor, please visit www.juvederm.com or like JUVÉDERM® on Facebook @Juvederm.
Please call our toll free number at 844.485.0104 for a consultation at one of our offices in Naples, Bonita Springs/Estero, or Fort Myers. For more information on Vobella:
Belotero / Juvederm Ultra & Ultra Plus / Restylane / Restylane Defyne / Restylane Refyne / Restylane Kysse/ Restylane Lyft / Restylane Silk / VolumaXC